Atomo Diagnostics Limited (ASX:AT1)
Australia · Delayed Price · Currency is AUD 0.0400
-0.0020 (-4.76%)
At close: Feb 5, 2026
Atomo Diagnostics Market Cap
Atomo Diagnostics has a market cap or net worth of 32.41 million as of February 5, 2026. Its market cap has increased by 166.84% in one year.
Market Cap
32.41M
Enterprise Value
29.37M
Revenue
3.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since April 16, 2020, Atomo Diagnostics's market cap has decreased from 218.82M to 32.41M, a decrease of -85.19%. That is a compound annual growth rate of -28.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 32.41M | 11.11% |
| Dec 31, 2025 | 29.17M | 140.15% |
| Dec 31, 2024 | 12.14M | -13.64% |
| Dec 29, 2023 | 14.06M | -54.38% |
| Dec 30, 2022 | 30.83M | -81.93% |
| Dec 31, 2021 | 170.58M | -1.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compumedics | 70.92M |
| Micro-X | 63.17M |
| CleanSpace Holdings | 50.95M |
| Nova Eye Medical | 48.42M |
| HeraMED | 41.72M |
| ImpediMed | 38.74M |
| CurveBeam AI | 37.90M |
| CONNEQT Health | 27.56M |